StockData
Context Therapeutics Inc. logo

Context Therapeutics Inc. (CNTX) stock

CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.17+0.01 (+3.07%)

Close on Nov 17, 2026Market cap $15.71MP/E –Yield –

Context Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Context Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 5.0×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−1.3
2025Dec 31, 20251.8×+0.9
2024Dec 31, 20240.9×−0.0
2023Dec 29, 20231.0×+0.7
2022Dec 30, 20220.3×–

More Context Therapeutics figures

See a number that looks wrong?